Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

JACC-Clinical Electrophysiology, published by Elsevier, stands as a leading journal in the fields of Cardiology and Physiology, with an esteemed Q1 ranking in both categories as of 2023. With an ISSN of 2405-500X and E-ISSN 2405-5018, this journal serves as an essential platform for disseminating cutting-edge research, clinical studies, and innovative practices related to electrophysiological aspects of cardiovascular health. Established in 2015, JACC-Clinical Electrophysiology has attracted high-quality submissions, reflected in its strong presence on Scopus, ranking 41st out of 387 in Cardiology and 15th out of 113 in Physiology (medical), placing it in the 89th and 87th percentiles respectively. Though it operates on a subscription model, its commitment to high standards of peer-reviewed scholarship makes it an indispensable resource for researchers, clinicians, and students dedicated to advancing knowledge and practice in electrophysiology and its impact on cardiac care. Join the community of leaders in the field by engaging with the latest findings and discussions published in this prestigious journal.

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

HEART RHYTHM is a leading academic journal published by Elsevier Science Inc, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. Established in 2004 and continuing its impactful journey through 2024, this journal holds an esteemed position within the academic community, boasting a 2023 Q1 ranking in both Cardiology and Cardiovascular Medicine and Medical Physiology, indicating its significant influence and contribution to these areas of study. With a commendable Scopus ranking—ranked #34 out of 387 in Cardiology and #11 out of 113 in Physiology—HEART RHYTHM is recognized for publishing high-quality research that drives advancements in understanding heart rhythms and associated medical conditions. Although it does not support open access, the journal remains accessible to professionals, researchers, and students, serving as a vital resource for the latest findings and theories in cardiovascular health. Invested in the mission to enhance knowledge and improve clinical practices, HEART RHYTHM stands as an essential publication for those aspiring to excel in the fields of cardiology and cardiovascular research.

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

Expert Review of Cardiovascular Therapy is a leading academic journal published by TAYLOR & FRANCIS INC, focusing on innovative and impactful research in the field of cardiovascular medicine. With an ISSN of 1477-9072 and an E-ISSN of 1744-8344, this journal serves as an essential resource for researchers, clinicians, and educators, offering a platform for the dissemination of critical advancements in cardiovascular therapy and internal medicine. Since its inception in 2003, the journal has maintained a reputable standing with a Q2 ranking in various categories including Cardiology and Cardiovascular Medicine, reflecting its influence and rigor in the field. The journal, which is based in the United Kingdom, does not currently offer Open Access options, ensuring that its content is accessible primarily to subscribers. With its commitment to high-quality, peer-reviewed articles, Expert Review of Cardiovascular Therapy is dedicated to bridging the gap between experimental research and clinical application, thereby enhancing patient care and therapeutic outcomes in cardiovascular health.

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

The World Journal for Pediatric and Congenital Heart Surgery, published by SAGE Publications Inc, is an authoritative resource dedicated to advancing the field of pediatric and congenital heart surgery. Since its inception in 2010, this journal has carved a niche for itself in the realms of pediatrics, cardiology, and surgery, with impressive quartile rankings reflecting its growing influence: Q2 in Pediatrics, Perinatology and Child Health, and Q2 in Surgery, alongside Q3 placements in Cardiology and Cardiovascular Medicine. This journal, which holds the ISSN 2150-1351 and E-ISSN 2150-0136, serves as a vital platform for researchers, clinicians, and students who are passionate about improving outcomes in pediatric cardiac care. Despite being a subscription-based publication, the journal underscores its commitment to disseminating high-quality research and critical reviews aimed at fostering collaboration and innovation in this specialized field, making it an essential read for anyone involved in pediatric healthcare.

EUROPACE, published by Oxford University Press, stands at the forefront of cardiovascular and physiological research, as evidenced by its prestigious Q1 categorization in both Cardiology and Cardiovascular Medicine and Physiology (medical) for 2023. With an impressive ranking of #39 out of 387 and #14 out of 113 in the relevant Scopus categories, EUROPACE is recognized for its rigorous peer-reviewed articles that significantly contribute to advancing knowledge in heart rhythm disorders and related approaches. The journal has been operational since 1999 and will continue shaping the future of cardiovascular research until 2024, making it a vital resource for researchers, clinicians, and students alike. Through its commitment to disseminating high-quality research, EUROPACE plays a crucial role in enhancing the understanding and treatment of cardiac conditions, thereby influencing clinical practice and improving patient outcomes across the globe.